Skip to main content

Krishnan Krish S's Form 4 filing

Krystal Biotech, Inc. (KRYS) · filed Apr 18, 2023

Accession no.
0001298709-23-000015
Filed
Apr 18, 2023
Trade date
Apr 17, 2023
Filing delay
1 day
Rule 10b5-1 plan
Checked

This filing lists 10 non-derivative transactions. Open-market sales total $4.38M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Krishnan Krish SCIK 0001298709Director, Officer (President and CEO), 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 17, 2023Common StockSSaleDisposed−1,050$85.55F2−$89,827.51,733,288Direct
Apr 17, 2023Common StockSSaleDisposed−4,298$86.80F3−$373,066.41,728,990Direct
Apr 17, 2023Common StockSSaleDisposed−9,428$87.41F4−$824,101.481,719,562Direct
Apr 17, 2023Common StockSSaleDisposed−9,724$88.41F5−$859,698.841,709,838Direct
Apr 17, 2023Common StockSSaleDisposed−500$89.12F6−$44,5601,709,338Direct
Apr 17, 2023Common StockSSaleDisposed−1,050$85.55F2−$89,827.51,676,213Indirect
Apr 17, 2023Common StockSSaleDisposed−4,297$86.80F3−$372,979.61,671,916Indirect
Apr 17, 2023Common StockSSaleDisposed−9,429$87.41F4−$824,188.891,662,487Indirect
Apr 17, 2023Common StockSSaleDisposed−9,724$88.41F5−$859,698.841,652,763Indirect
Apr 17, 2023Common StockSSaleDisposed−500$89.12F6−$44,5601,652,263Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The transaction was executed in multiple trades ranging from $85.0500 to $86.0000. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

Referenced by the price of 2 transactions in Table I.

F3

The transaction was executed in multiple trades ranging from $86.0500 to $87.0450. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

Referenced by the price of 2 transactions in Table I.

F4

The transaction was executed in multiple trades ranging from $87.0500 to $88.0300. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

Referenced by the price of 2 transactions in Table I.

F5

The transaction was executed in multiple trades ranging from $88.0500 to $89.0100. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

Referenced by the price of 2 transactions in Table I.

F6

The transaction was executed in multiple trades ranging from $89.0650 to $89.2300. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

Referenced by the price of 2 transactions in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)